期刊文献+

NF-κB、TGF-β1在糖尿病大鼠心肌及主动脉中的表达 被引量:4

The Expression of NF-κB and TGF-β1 in the Myocardium and Aorta of STZ-induced Diabetic Rats
下载PDF
导出
摘要 目的:探讨链脲佐菌素(STZ)诱导的糖尿病(DM)大鼠心肌及主动脉核转录因子-κB(NF-κB)、转化生长因子-β1(TGF-β1)的表达。方法:用HE及MASSON染色观察DM大鼠心肌及主动脉的病理改变,用免疫组化的方法检测上述免疫因子的表达。结果:DM大鼠心肌、主动脉NF-κB、TGF-β1表达均明显高于正常对照组(CON),差异有统计学意义(P<0.01)。结论:NF-κB和TGF-β1在DM心血管并发症的发生发展机制中起重要作用。 Objective To observe the expression of Nuclear factor-κB(NF-κB)and Transforming growth factor-β1(TGF-β1)in the myocardium and aorta of diabetic rats induced by STZ.Methods 20 male Wister rats were divided into two groups.10 rats without any treatment were served as control group.10 rats were diabetic rats induced by STZ.At 34 weeks,20 male Wister rats were sacrificed for pathological and Immunohistochemical study.The pathological changes were assessed by HE and Masson staining.The expression of cytokines(NF-κB and TGF-β1)in the myocardium and aorta of diabetic rats was assessed with immunohistochemistry.Results In comparison with control group,the expressions of NF-κB and TGF-β1 in the myocardium and aorta of diabetic rats induced by STZ were significantly increased(both P0.01).Conclusions The NF-κB and TGF-β1 may play a critical role in the pathogenesis of the chronic diabetic cardiovascular complications.
作者 周叶 邱明才
出处 《心脑血管病防治》 2010年第3期186-187,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 糖尿病性 TGF-Β1 NF-ΚB 大鼠心肌 主动脉 2型糖尿病 皮肤活检 心血管疾病 Diabetes mellitus rats Myocardium Aorta Immunoglobulin Nuclear factor-κB Transforming growth factor-β1
  • 相关文献

参考文献6

二级参考文献14

  • 1杜勇,杨念生,李幼姬,姜宗培,姜傥,余学清.2型糖尿病患者合并非糖尿病肾损害的临床病理分析[J].中华糖尿病杂志(1006-6187),2004,12(6):409-412. 被引量:20
  • 2高桦,邱明才.应加强对部分2型糖尿病患者多器官免疫损伤的研究[J].中华医学杂志,2005,85(12):793-795. 被引量:46
  • 3Zhang J .Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol - anchored complement inhititors in human and experimental diabetic relcnopathy. Diabetes, 2002, 51(12) : 3499-3504.
  • 4Baudouin C,Fredj-Reygrobellet D,Lapalus P,et al.Immunohistopathologic findings in proliferative diabetic retinopathy.Am J Opthalmol,1988,105:383-388.
  • 5Zhang J.Gerhardinger C,Lorenzi M.Early complement activation and decreased levels of glycasylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopthy.Diabetes,2002,51:3499-3504.
  • 6Gerl VB,Bohl J,Pitz S,et al.Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.Invest Ophthalmol Vis Sci,2002,43:1104-1108.
  • 7Slepova OS,Gerasimenko VA,Makarov VP,et al.Comparative study of the role of cytokines in different forms of eye diseases.Tumor necrosis factor-alpha.Vestn Oftalmol,1998,114:28-32.
  • 8Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly.Diabetes,2001,50:2384-2389.
  • 9Joussen AM,Poulaki V,Mitsiades N,et al.Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-suppression.FASEB J,2002,16:438-440.
  • 10夏邦顺,陈玉石,周银芳,周芯,耿健敏.TNF-α在伴有血管病变的NIDDM患者胰岛素抵抗发生中的意义[J].中国免疫学杂志,1998,14(2):147-148. 被引量:6

共引文献76

同被引文献64

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部